Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of recurrent urinary tract infections in postmenopausal women
ACTRN12616000410459Phase 3Not yet recruiting
- Sponsor
- Prof Damon Eisen
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in urinary tract infection (UTI) (4 arms), sponsored by Prof Damon Eisen. Primary endpoints: Frequency of urinary tract infection and Time to first breakthrough urinary tract infection. Planned start May 2017; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ACTRN12616000410459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000410459.